Prognostic model of lung adenocarcinoma based on immunoprognosis-related genes and related drug prediction

This is the authors' abstract. We don't add key points for this paper.

Lung cancer (LC) is the most common malignant tumor in the world, and lung adenocarcinoma (LUAD) is the most common type of LC. Immune microenvironment plays a critical role in cancer from onset to relapse. We aimed to identify an effective immune-related prediction model for assessing prognosis and predicting the relevant tumor therapeutic drugs.